PharmacoPlatform: Gateways ICSR ICH E2B(R3), Pontuação de Desproporcionalidade e Mineração de Sinais
A PharmacoPlatform fornece arquiteturas de software de farmacovigilância (PV) corporativas, automatizando a ingestão de Relatórios de Segurança de Casos Individuais (ICSR), extração de eventos adversos médicos via PLN a partir de relatos espontâneos e mídias sociais, e detecção de sinais de desproporcionalidade sob normas FDA FAERS e EMA EudraVigilance.
PharmacoPlatform Global Pharmacovigilance & Signal Detection Pipeline
Multichannel safety intake, MedDRA NLP normalization, and disproportionality scoring
Central System: Pharmacovigilance Core - E2B(R3) Engine & Disproportionality Analyzer
Clinical IoMT Nodes
- Multichannel Safety Intake Sink
- Clinical NLP / MedDRA Auto-Coder
- Individual Case Safety Report (ICSR) Core
- Disproportionality Signal Engine
- Regulatory Gateway Dispatcher
Architectural Layers & Regulatory Standards
- Multisource Adverse Event Ingestion (Optical Character Recognition (OCR) / Multi-Tenant Intake APIs): Ingesting adverse event reports from clinical trials, spontaneous patient hotlines, scientific literature, and social platforms.
- Medical Ontology Normalization (Clinical Transformer Models / MedDRA Dictionary v26+): Mapping unstructured patient symptom descriptions into standardized Medical Dictionary for Regulatory Activities (MedDRA) terms.
- Statistical Signal Detection & Disproportionality (Bayesian Confidence Propagation Neural Network (BCPNN)): Computing Proportional Reporting Ratios (PRR) and empirical Bayes geometric means to detect emerging safety signals.
- Automated Regulatory Electronic Submission (AS2 Secure Gateway / E2B(R3) XML Validator): Validating and transmitting expedited 7-day and 15-day safety reports to FDA FAERS and EudraVigilance.
Key Metrics: < 15 min (Automated ICSR Processing Time) | 99.4% (MedDRA Coding Accuracy) | 100% (ICH E2B(R3) XML Schema Compliance) | Real-Time (Adverse Signal Disproportionality Mining)
Farmacovigilância Automatizada, Relatórios de Segurança E2B(R3) e Detecção de Sinais de Reação Adversa a Medicamentos (RAM)
Referência técnica de engenharia autoritativa para automated pharmacovigilance, e2b(r3) safety reporting & adverse drug reaction (adr) signal detection em submissões FDA 510(k)/PMA, EU MDR, ciclo de vida IEC 62304 Classe C, ISO 13485 e interoperabilidade IoMT com segurança zero-trust.
Core Engineering Areas
Technical Articles
Related Cluster Architecture Specifications
- HealthVigilance — Zero-Trust IoMT Architecture, SaMD Risk Engineering & Autonomous Clinical Post-Market Vigilance
- AgenticSaMD — Autonomous Agentic Software as a Medical Device, Multi-Agent Clinical Decision Support & FDA GMLP Guardrails
- AITelemonitoring — Autonomous AI Telemonitoring, Virtual Nursing Assistants & Predictive Clinical Deterioration Scoring
- BCI2IoMT — Brain-Computer Interface IoMT Gateways, Neural Decoding & Electrophysiological Streaming